AB
KRYS icon

Amalgamated Bank’s Krystal Biotech KRYS Stock Holding History

Amalgamated Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
7,045
-334
-5% -$99.8K 0.02% 707
2026
Q1 		$1.91M Sell
7,379
-107
-1% -$28.5K 0.01% 822
2025
Q4 		$1.85M Buy
7,486
+70
+0.9% +$14.7K 0.01% 855
2025
Q3 		$1.31M Buy
7,416
+190
+3% +$28.4K 0.01% 976
2025
Q2 		$993K Buy
7,226
+26
+0.4% +$3.82K 0.01% 1044
2025
Q1 		$1.3M Sell
7,200
-236
-3% -$39.7K 0.01% 935
2024
Q4 		$1.17M Buy
7,436
+2
+0% +$355 0.01% 1002
2024
Q3 		$1.35M Sell
7,434
-143
-2% -$27.6K 0.01% 952
2024
Q2 		$1.39M Buy
7,577
+6,847
+938% +$1.15M 0.01% 954
2024
Q1 		$130K Sell
730
-2,373
-76% -$330K ﹤0.01% 1681
2023
Q4 		$385K Sell
3,103
-217
-7% -$24.1K ﹤0.01% 1542
2023
Q3 		$385K Buy
3,320
+41
+1% +$5K ﹤0.01% 1538
2023
Q2 		$385K Buy
3,279
+777
+31% +$79.3K ﹤0.01% 1560
2023
Q1 		$200K Sell
2,502
-523
-17% -$41.1K ﹤0.01% 1803
2022
Q4 		$240K Buy
3,025
+81
+3% +$6.01K ﹤0.01% 1788
2022
Q3 		$205K Buy
2,944
+70
+2% +$5.06K ﹤0.01% 1839
2022
Q2 		$189K Buy
2,874
+437
+18% +$27.2K ﹤0.01% 1900
2022
Q1 		$162K Buy
+2,437
New +$152K ﹤0.01% 2023

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Amalgamated Bank's KRYS Position: Q2 2026 in Review

Amalgamated Bank reduced its Krystal Biotech (KRYS) stake by 4.5% in Q2 2026, selling an estimated $99.8K and leaving 7,045 shares worth $2.62M. The position accounts for 0.02% of the portfolio, ranked #707.

Amalgamated Bank first reported a position in KRYS in Q1 2022 and has held it in 18 quarters since. 207 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Amalgamated Bank held 7,045 shares of Krystal Biotech worth $2.62M as of Q2 2026.
  • Amalgamated Bank sold 334 Krystal Biotech shares in Q2 2026, an estimated $99.8K.
  • Krystal Biotech made up 0.02% of Amalgamated Bank's portfolio in Q2 2026, its #707 holding.
  • Amalgamated Bank first reported a position in Krystal Biotech in Q1 2022 and has held it in 18 quarters since.
  • 207 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.